Primary Care Doctors Receiving Specialized Training Can Diagnose Autism
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, July 18, 2023 -- In most cases, community-based primary care clinicians who receive specialized training can accurately diagnose autism spectrum disorder (ASD), according to a study published online July 18 in Pediatrics.
Rebecca McNally Keehn, Ph.D., from the Indiana University School of Medicine in Indianapolis, and colleagues examined the diagnostic accuracy of the Early Autism Evaluation (EAE) Hub system, which provides specialized training and collaborative support to community primary care providers for diagnosing young children at risk for ASD. Children aged 14 to 48 months were referred by EAE Hub clinicians for follow-up expert evaluation. The primary outcome was agreement of categorical ASD diagnosis between EAE Hub clinician and ASD expert (index diagnosis and reference standard).
The researchers found that 82 percent of the 126 children had consistent ASD outcomes between the index and reference evaluation. Sensitivity and specificity were 81.5 and 82.4 percent, respectively, and the positive and negative predictive values were 92.6 and 62.2 percent, respectively. No difference was seen in accuracy by EAE Hub clinician or site. Significant differences between true-positive and false-negative cases were seen across measures of development, with greater impairment evident for true-positive cases.
"The study of innovative diagnostic models has important implications for how future population health solutions that address the ASD diagnosis crisis are designed and implemented," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
![](/img/logo/vendor/healthday-logo.png)
© 2024 HealthDay. All rights reserved.
Posted July 2023
Read this next
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
Self-Administered Gerocognitive Exam Improves Detection of Cognitive Issues in Primary Care
TUESDAY, July 2, 2024 -- A self-administered gerocognitive examination (SAGE) is easily incorporated into primary care provider (PCP) visits, and its use significantly increases...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.